Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/7/2017
SIETES contiene 91904 citas

 
 
 1 a 20 de 49 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Chobanian AV. Hypertension in 2017- What is the right target?. JAMA 2017;317:579-80. [Ref.ID 101415]
2.Enlace a cita original
Pfeffer MA, McMurray JJV. Lessons in uncertainty and humility — Clinical trials involving hypertension. N Engl J Med 2016;375:1756-66. [Ref.ID 100966]
3.Tiene citas relacionadas Cita con resumen
4. Cita con resumen
Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA, Booth GL, for the ACCORD Study Group. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet 2014;384:1936-41. [Ref.ID 98368]
5. Cita con resumen
Slomski A. Avoiding hypoglycemia at all costs is crucial for some with diabetes. JAMA 2013;309:2536-7. [Ref.ID 95732]
6. Cita con resumen
Anónimo. HbA1c targets in type 2 diabetes: guidelines and evidence. Drug Ther Bull 2013;51:42-5. [Ref.ID 95196]
7. Cita con resumen
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011;343:1136. [Ref.ID 91918]
8. Cita con resumen
Badgett R, Dong F, Aung K. Plotting surrogate outcomes. Arrow plots show way forward. BMJ 2011;343:654. [Ref.ID 91722]
9.Tiene citas relacionadas
Gerstein HC, Miller ME, Rosenberg YD. Intensive glucose lowering and cardiovascular outcomes. Author/editor response. N Engl J Med 2011;364:2264. [Ref.ID 90746]
10.Tiene citas relacionadas
Fan Y, Zhang AM, Xiao YB. Intensive glucose lowering and cardiovascular outcomes. N Engl J Med 2011;364:2263-4. [Ref.ID 90745]
11.Tiene citas relacionadas
Winterstein AG, Heckbert SR, Schambelan M. Intensive glucose lowering and cardiovascular outcomes. N Engl J Med 2011;364:2263. [Ref.ID 90744]
12. Cita con resumen
Brett AS. Year in review for 2010. Journal Watch 2011;31:4-5. [Ref.ID 90084]
13.Tiene citas relacionadas Cita con resumen
The ACCORD Study Group. Long term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011;364:818-28. [Ref.ID 90063]
14. Cita con resumen
Pogach L, Aron DC. Sudden accelaration of diabetes quality measures. JAMA 2011;305:709-10. [Ref.ID 90030]
15.Tiene citas relacionadas Cita con resumen
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm Jr RH, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I, for the ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010;376:419-30. [Ref.ID 89075]
16.Tiene citas relacionadas
Klein R. Intensive treatment of hyperglycaemia: ACCORD. Lancet 2010;376:391-2. [Ref.ID 89068]
17.Tiene citas relacionadas
Klein BEK. Reduction in risk of progression of diabetic retinopathy. N Engl J Med 2010;363:287-8. [Ref.ID 88619]
18.Tiene citas relacionadas Cita con resumen
The ACCORD Study Group and ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233-44. [Ref.ID 88618]
19.Tiene citas relacionadas Cita con resumen
Nilsson PM. ACCORD and risk-factor control in type 2 diabetes. N Engl J Med 2010;362:1628-30. [Ref.ID 88348]
20.Tiene citas relacionadas Cita con resumen
The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-85. [Ref.ID 88346]
Seleccionar todas
 
 1 a 20 de 49 siguiente >>